UA58642U - method for treating inflammatory and dystrophic and inflammatory periodontal diseases - Google Patents

method for treating inflammatory and dystrophic and inflammatory periodontal diseases

Info

Publication number
UA58642U
UA58642U UAU201008401U UAU201008401U UA58642U UA 58642 U UA58642 U UA 58642U UA U201008401 U UAU201008401 U UA U201008401U UA U201008401 U UAU201008401 U UA U201008401U UA 58642 U UA58642 U UA 58642U
Authority
UA
Ukraine
Prior art keywords
inflammatory
dystrophic
periodontal diseases
treating
treating inflammatory
Prior art date
Application number
UAU201008401U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Николай Николаевич Колотилов
Константин Евгеньевич Печковский
Ирина Михайловна Печковская
Original Assignee
Государственное Учреждение "Научно-Практический Центр Лучевой Диагностики Амн Украины"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственное Учреждение "Научно-Практический Центр Лучевой Диагностики Амн Украины" filed Critical Государственное Учреждение "Научно-Практический Центр Лучевой Диагностики Амн Украины"
Priority to UAU201008401U priority Critical patent/UA58642U/en
Publication of UA58642U publication Critical patent/UA58642U/en

Links

Landscapes

  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)

Abstract

A method for treating inflammatory and dystrophic and inflammatory periodontal diseases comprises the application of drug composition containing clay, non-steroidal anti-inflammatory agent, antibacterial agent. The bentonite clay is used containing smectite dioktahedral.
UAU201008401U 2010-07-05 2010-07-05 method for treating inflammatory and dystrophic and inflammatory periodontal diseases UA58642U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201008401U UA58642U (en) 2010-07-05 2010-07-05 method for treating inflammatory and dystrophic and inflammatory periodontal diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201008401U UA58642U (en) 2010-07-05 2010-07-05 method for treating inflammatory and dystrophic and inflammatory periodontal diseases

Publications (1)

Publication Number Publication Date
UA58642U true UA58642U (en) 2011-04-26

Family

ID=50832513

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201008401U UA58642U (en) 2010-07-05 2010-07-05 method for treating inflammatory and dystrophic and inflammatory periodontal diseases

Country Status (1)

Country Link
UA (1) UA58642U (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2642648C2 (en) * 2016-05-31 2018-01-25 Федеральное государственное автономное образовательное учреждение высшего образования "Крымский федеральный университет имени В.И. Вернадского" Method of treating inflammatory periodontal and oral mucosal diseases

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2642648C2 (en) * 2016-05-31 2018-01-25 Федеральное государственное автономное образовательное учреждение высшего образования "Крымский федеральный университет имени В.И. Вернадского" Method of treating inflammatory periodontal and oral mucosal diseases

Similar Documents

Publication Publication Date Title
CL2012003602A1 (en) Fused nitrogen heterocyclic compounds, phosphodiesterase modulators; a medication; a method to prevent or treat schizophrenia; and its use for the production of an agent to prevent or treat schizophrenia.
PH12016500072B1 (en) Piperidinyl-indole derivatives complement factor b inhibitors and uses thereof
CO6531458A2 (en) NEW SPYROPIPERIDINE COMPOUNDS
UA111161C2 (en) PHTALASINONCETONE DERIVATIVE, METHOD OF PREPARATION AND PHARMACEUTICAL APPLICATION
CY1117143T1 (en) NEW CARBONYLYLENED (AZA) CYCLOXANS AS D3 DOPAMINE CONTAINERS
CL2009000426A1 (en) Compounds derived from carbocyclyl / heterocyclyl-pyridin-2-yl-urea, bacterial topoisomerase iv inhibitors; pharmaceutical composition; and its use for the treatment of bacterial infections
EA201590118A1 (en) PYRROLIDINE DERIVATIVES AND THEIR APPLICATION AS MODULATORS OF THE COMPLEMENT ACTIVATION
NZ591728A (en) Cephalosporin having catechol group
CL2016000117A1 (en) Autotaxin inhibitors comprise a heteroaromatic ring-benzylamine basic cycle
ECSP12011930A (en) NEW SPYROPIPERIDINE COMPOUNDS
CL2009000882A1 (en) A compound n- (4-chloro-3- (pyridin-2-yl) phenyl) -4- (2-hydroxy-2-methylpropylsulfonyl) -2-methylbenzamide, inhibitor of the hedgehog signaling pathway; pharmaceutical composition comprising said compound; and its use to treat cancer.
UA107423C2 (en) Fluoro-pyridinone derivatives useful as antibacterial agents
HN2010001920A (en) DIHYDROPIRAZOLONAS REPLACED AS INHIBITORS OF HIF- PROPIL-4-HYDROXYLASE
IN2015DN00185A (en)
MY162535A (en) Inhibitors of arginase and their therapeutic applications
MX2016000675A (en) Aminomethyl-biaryl derivatives as complement factor d inhibitors and uses thereof.
PH12014502462A1 (en) Complement pathway modulators and uses thereof
ECSP11011151A (en) PURINE COMPOUNDS
MX2009001494A (en) 2-aminobenzoxazole carboxamides as 5ht3 modulators.
UA111972C2 (en) Pharmaceutical compositions comprising rifaximin, processes for their preparation and their use in the treatment of vaginal infections
MX2013002851A (en) Inhibitors of notum pectinacetylesterase and methods of their use.
NZ707366A (en) Novel histone deacetylase inhibitors and their use in therapy
CL2009000949A1 (en) Compounds derived from 1,2,3,5-tetrahydro-indolizine, 6,7,8,9-tetrahydro-4h-quinolizine substituted, inhibitors of mek kinase activity; its pharmaceutical composition; its use for the treatment of hyperproliferative diseases, such as cancer and inflammation.
UA58642U (en) method for treating inflammatory and dystrophic and inflammatory periodontal diseases
CL2008003062A1 (en) Compounds derived from spiro-conjugated pyrazoles, inhibitors of ksp kinesin activity; pharmaceutical composition comprising said compound; and use of the compound for the treatment of proliferative diseases.